Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: First we need more real money from the MMP to decide the next steps or strategy

STRATEGY???

1ST Priority - MMP, 1,500 Co's paying cash and infringing co's shares plus discount share options for a license plus royalties to PTSC.

2ND Priority - MMP, 1,500 Co's paying cash and infringing co's shares plus discount share options for a license plus royalties to PTSC.

Three tranches of $500m, if that were to be achieved.

Tranch A - $0.50 per share dividend, plus commencement of share buybacks.

Tranch B - $0.25 per share dividend, buybacks and excercise share option purchases in the infringing co's.

Tranch B - $0.25 per share dividend, buybacks and excercise further share option purchases in the infringing co's.

NO BUYING OF OTHER SEXED UP BASKET BUSINESES WHATSOEVER !!!

HAPPY FIRST OF FEBRUARY.

Cheers

ZR

Share
New Message
Please login to post a reply